| Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-21-155 |
R15
|
May 19, 2021 |
May 08, 2024 |
| CCRP Initiative—Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)- RFA-ES-21-006 |
R01
|
June 25, 2021 |
September 21, 2023 |
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)- PAR-20-253 |
R21
|
July 07, 2020 |
May 31, 2023 |
| Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)- PAR-21-070 |
R61/R33
|
November 13, 2020 |
March 18, 2023 |
| Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 |
R61/R33
|
March 10, 2022 |
August 04, 2022 |
| Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)- PAR-20-298 |
R01
|
September 09, 2020 |
December 08, 2023 |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 |
R01
|
May 10, 2022 |
May 08, 2025 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 |
R21
|
May 10, 2022 |
May 08, 2025 |
| Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)- PAR-21-109 |
R21
|
January 11, 2021 |
May 08, 2024 |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 |
R01
|
March 29, 2022 |
August 04, 2022 |
| Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)- RFA-AI-21-035 |
R21
|
March 17, 2021 |
July 07, 2023 |
| Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 |
R01
|
October 24, 2019 |
September 08, 2022 |
| Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)- PAR-21-253 |
R01
|
July 06, 2021 |
October 20, 2023 |
| Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 |
R01
|
March 02, 2022 |
July 09, 2022 |
| Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)- PAR-20-158 |
R01
|
March 31, 2020 |
July 29, 2022 |
| International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)- PAR-20-108 |
R01
|
February 04, 2020 |
August 20, 2022 |
| Intervention Research To Improve Native American Health (R01 Clinical Trial Optional)- PAR-20-238 |
R01
|
August 17, 2020 |
September 08, 2023 |
| INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)- RFA-OD-21-007 |
R21
|
September 24, 2021 |
July 02, 2024 |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-20-139 |
R01
|
March 13, 2020 |
January 14, 2023 |
| Limited Competition—Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)- PAR-20-291 |
R21
|
September 14, 2020 |
September 08, 2023 |
| Limited Competition—Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)- PAS-21-245 |
R34
|
June 14, 2021 |
September 08, 2024 |
| Limited Competition—Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed)- PAR-20-290 |
R03
|
September 14, 2020 |
September 08, 2023 |
| Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-050 |
R01
|
June 27, 2022 |
December 08, 2022 |
| New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)- RFA-AI-20-076 |
R01
|
October 20, 2020 |
March 18, 2023 |
| NIAID Clinical Trial Planning Grant (R34 Clinical Trials Not Allowed)- PAR-20-270 |
R34
|
August 05, 2020 |
May 13, 2023 |
